-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Mirum Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q2 2024.
- Mirum Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $635K, a 101% increase year-over-year.
- Mirum Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $1.73M.
- Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $991K.
- Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$6.41M.
- Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $37K, a 517% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)